None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy female subjects aged 18 45 years Visible mild to moderate pigmentation in external intimate area Good general and gynecological health Willing to comply with study requirements Provide written informed consent
Exclusion criteria
Exclusion criteria: Pregnant or breastfeeding women Active infections, lesions, or dermatoses in intimate area History of hypersensitivity to cosmetic/intimate products Use of: Topical treatments in intimate area (within 2 weeks) Systemic medication affecting skin (within 4 weeks) Sexually transmitted infections (current or recent) Participation in another clinical/cosmetic study within 30 days Any condition that may interfere with evaluation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the reduction in darkness (skin lightening/pigmentation) in the intimate area after 28 days of product useTimepoint: To assess the reduction in darkness (skin lightening/pigmentation) in the intimate area after 28 days of product use | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate fresh feeling throughout the day To assess skin comfort and irritation To evaluate overall subject satisfaction Timepoint: 28 Days | — |
Countries
India
Contacts
Punawale Multispecialty Hospital